NanoViricides
NNVC
28 hedge funds and large institutions have $4.22M invested in NanoViricides in 2021 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 8 reducing their positions, and 8 closing their positions.
184% more call options, than puts
Call options by funds: $332K | Put options by funds: $117K
1.39% less ownership
Funds ownership: 9.29% → 7.9% (-1.4%)
18% less funds holding
Funds holding: 34 → 28 (-6)
25% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 8
47% less capital inflows, than outflows
Capital inflows: $419K | Capital outflows: $783K
75% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$164K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$138K |
| 3 |
Compagnie Lombard Odier SCmA
1204 Geneva,
Switzerland
|
+$80.7K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$20.6K |
| 5 |
AW
Alaethes Wealth
Glenbrook,
Nevada
|
+$8.61K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$157K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$122K |
| 3 |
Tower Research Capital (TRC)
New York
|
-$113K |
| 4 |
BAM
Blueshift Asset Management
Red Bank,
New Jersey
|
-$95K |
| 5 |
Bridgeway Capital Management
Houston,
Texas
|
-$88.8K |
NNVC Hedge Fund Activity: Q2 2021 in Review
28 of the 5,769 institutional investors tracked by Wall St. Rank reported a position in NanoViricides (NNVC) for Q2 2021, worth a combined $4.22M — down 9.8% from $4.68M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of NNVC and 2 opened new positions — a net loss of 6 holders — while 8 trimmed existing stakes and 6 added.
The largest buyer was State Street, opening a new position worth an estimated $164K. The largest seller was BlackRock, cutting an estimated $157K.
- 28 institutional investors held NanoViricides (NNVC) as of Q2 2021, down from 34 in Q1 2021.
- Funds reported $4.22M of NanoViricides stock for Q2 2021, down 9.8% quarter-over-quarter.
- 2 funds opened new NanoViricides positions in Q2 2021 and 8 closed out, a net change of -6 holders.
- The largest NanoViricides buyer in Q2 2021 was State Street, an estimated $164K added.
- The largest NanoViricides seller in Q2 2021 was BlackRock, an estimated $157K sold.
Based on aggregated 13F filings for Q2 2021.